Disclosures for "Diagnostic Yield of Rapid Whole Genome Sequencing in Hospitalized Adults with Unexplained Neurological Manifestations"
-
Mr. Amanat has nothing to disclose.
-
Dr. Toledano has nothing to disclose.
-
The institution of Dr. Schimmenti has received research support from Mayo Clinic.
-
Dr. pichurin has nothing to disclose.
-
Dr. Deyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biomarin.
-
Dr. Jabs has stock in Baxter. Dr. Jabs has stock in DOW. Dr. Jabs has stock in Dupont. Dr. Jabs has stock in Takeda Pharmaceutical. The institution of Dr. Jabs has received research support from NIH. Dr. Jabs has received publishing royalties from a publication relating to health care. Dr. Jabs has received personal compensation in the range of $500-$4,999 for serving as a National Advisory Child Health and Human Development Council Member with NIH.
-
Dr. Dhamija has nothing to disclose.